TXMD Stock Price | TherapeuticsMD Inc P/E, Revenue, EPS, & Forecasts

TherapeuticsMD Inc • TXMD

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About TherapeuticsMD Inc

Ticker

TXMD

Trading on

NASDAQ

ISIN

US88338N1072

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

CEO

Headquarters

951 Yamato Road, Boca Raton, FL, United States, 33431

Employees

Website

therapeuticsmd.com

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Metrics

BasicAdvanced

Market cap

$12.8M

P/E ratio

EPS

-$0.20

Dividend Yield

0.00%

Beta

0.95

Forward P/E ratio

2.29

EBIDTA

$-3M

Ex dividend date

Price & volume

Market cap

$12.8M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

2.29

PEG ratio

-0.73

Trailing P/E

Price to sales

7.27

Price to book

0.46

Earnings

EPS

-$0.20

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-3M

Revenues (TTM)

$1.8M

Revenues per share (TTM)

$0.15

Technicals

Beta

0.95

52-week High

$2.25

52-week Low

$0.70

50-day moving average

$0.93

200-day moving average

$1.35

Short ratio

2.31

Short %

2.00%

Management effectiveness

ROE (TTM)

8.16%

ROA (TTM)

5.32%

Profit margin

123.85%

Gross profit margin

$1.8M

Operating margin

46.78%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

32.90%

Share stats

Outstanding Shares

11.5M

Float

9.5M

Insiders %

1.95%

Institutions %

30.50%

Analyst Insights & forecasts

0% Buy

100% Hold

0% Sell

Based on information from 1 analysts.

Average price target

$5.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.08

$0.03

355.33%

Q1 • 24Beat

-$0.09

Q2 • 24Beat

-$0.05

Q3 • 24Beat

$0.02

Q4 • 24Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$0.5M

$-0.6M

111.33%

Q3 • 24

$0.7M

$0.3M

37.78%

Q4 • 24

21.94%

141.38%

133.93%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$39.6M

$12.5M

31.50%

Q3 • 24

$38.8M

$11.5M

29.50%

Q4 • 24

1.85%

8.08%

6.35%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-0.2M

$0M

$-0.1M

Q3 • 24

$0M

Q4 • 24

109.19%

NaN%

123.94%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a TherapeuticsMD Inc share?

TherapeuticsMD Inc shares are currently traded for undefined per share.

How many shares does TherapeuticsMD Inc have?

TherapeuticsMD Inc currently has 11.5M shares.

Does TherapeuticsMD Inc pay dividends?

No, TherapeuticsMD Inc doesn't pay dividends.

What is TherapeuticsMD Inc 52 week high?

TherapeuticsMD Inc 52 week high is $2.25.

What is TherapeuticsMD Inc 52 week low?

TherapeuticsMD Inc 52 week low is $0.70.

What is the 200-day moving average of TherapeuticsMD Inc?

TherapeuticsMD Inc 200-day moving average is $1.35.

Who is TherapeuticsMD Inc CEO?

The CEO of TherapeuticsMD Inc is -.

How many employees TherapeuticsMD Inc has?

TherapeuticsMD Inc has 1 employees.

What is the market cap of TherapeuticsMD Inc?

The market cap of TherapeuticsMD Inc is $12.8M.

What is the P/E of TherapeuticsMD Inc?

The current P/E of TherapeuticsMD Inc is null.

What is the EPS of TherapeuticsMD Inc?

The EPS of TherapeuticsMD Inc is -$0.20.

What is the PEG Ratio of TherapeuticsMD Inc?

The PEG Ratio of TherapeuticsMD Inc is -0.73.

What do analysts say about TherapeuticsMD Inc?

According to the analysts TherapeuticsMD Inc is considered a hold.